TMCnet News

US PT and APTT POC/Point-of-Care Market 2017-2021 Shares and Segment Forecasts - Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers - ResearchAndMarkets.com
[January 19, 2018]

US PT and APTT POC/Point-of-Care Market 2017-2021 Shares and Segment Forecasts - Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers - ResearchAndMarkets.com


The "US PT and APTT POC/Point-of-Care Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

This report provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

This report covers the following:

  • Five-year test volume and reagent sales forecasts for coagulation procedures by market segment.
  • Sales and market shares of major reagent and instrument suppliers.
  • Analysis of coagulation procedures performed in POC testing locations.
  • Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
  • Emerging technologies and their applicatios for POC testing.
  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.



Companies Profiled:

  • Abbott
  • ADI/America n Diagnostica
  • Agilent Technologies
  • Alere/Biosite/Inverness
  • Axis (News - Alert)-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • Bio/Data
  • Biomerieux
  • Cephid
  • Chrono-Log
  • Corgenix
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio
  • Grifols
  • Helena Laboratories
  • Hologic/Gen-Probe
  • Horiba
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech /Leica
  • Kyowa Medex
  • Lonza
  • Mackay (News - Alert) Life Sciences
  • Matritech/Alere
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens (News - Alert)
  • Sienco
  • Sysmex
  • Takara Bio
  • ThermoFisher
  • Tosoh
  • Wako
  • Zycare/Alere

Key Topics Covered:


1. Introduction

2. Executive Summary

3. Rationale for Testing Decentralization

4. Worldwide Market and Technology Overview

5. Instrumentation: Coagulation Analyzers Manufactured by:

6. Current and Emerging Technologies

7. Major Product Development Opportunities

8. Design Criteria for Decentralized Testing Products

9. Alternative Market Penetration Strategies

For more information about this report visit https://www.researchandmarkets.com/research/t89gx2/us_pt_and_aptt?w=4


[ Back To TMCnet.com's Homepage ]